MDAI
Spectral AI, Inc.
$1.82
-2.15%
$57.9M
No data for this timeframe.
Vol
Market Cap$57.9M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders9 funds
Inst. Value$1.8M
Inst. Activity1 buys / 0 sells
Reddit Sentiment85° Bullish
Press Releases3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001833498·Prev Close $1.86
Recent Activity
May 29, 2026
Insider
DiMaio John Michael was granted 15,000 shares
Director @ $2.12 ($31.8K)
May 28, 2026
Insider
DiMaio John Michael was granted 2,500 shares
Director @ $2.36 ($5.9K)
May 26, 2026
Insider
DiMaio John Michael was granted 32,233 shares
Director @ $2.61 ($84.1K)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
6,489 shares ($9.5K)
Inst.
VANGUARD GROUP INC — ADD
842,049 shares ($1.2M)
Jun 12, 2026
other
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
<p align="justify">DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MD
Mar 24, 2026
Press
Spectral AI reported FY 2025 revenue of $19.7 million, down 33.5% YoY, with Q4 revenue halving to $3.8 million due to re
Impact 6/10
Mar 18, 2026
Press
Spectral AI (MDAI) announced $31.7 million in additional non-dilutive funding from BARDA to advance development of its D
Impact 8/10
Price Targets
$5.42
+197.6% upside
Strong Buy
Current $1.82
Low $4.00
Median $6.00
High $6.25
3 analysts
$4.00
$6.25
Analyst Ratings
3Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 27, 2026 | BTIG | MAINTAIN | Buy → Buy |
| May 26, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Mar 25, 2026 | BTIG | REITERATE | Buy → Buy |
| Feb 10, 2026 | BTIG | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.14 | $-0.14 — $-0.14 | 55% YoY | 1 |
| Next Q | $-0.14 | $-0.14 — $-0.14 | -8% YoY | 1 |
| Current FY | $-0.53 | $-0.53 — $-0.53 | -83% YoY | 1 |
| Next FY | $-0.94 | $-0.94 — $-0.94 | -77% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1M | — |
| VANGUARD FIDUCIARY TRUST CO | $208.4K | — |
| BlackRock, Inc. | $179.7K | DOUBLED |
| Rathbones Group PLC | $128.0K | NEAR_EXIT |
| STATE STREET CORP | $111.1K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 29, 2026 | DiMaio John | A | $31.8K |
| May 28, 2026 | DiMaio John | A | $5.9K |
| May 26, 2026 | DiMaio John | A | $84.1K |
| May 18, 2026 | Cotton Richard | A | $21.2K |
| May 15, 2026 | DiMaio John | A | $4.0K |
Reddit Sentiment
85°▼
Bullish
Bearish
Neutral
Bullish
9 institutional holders with $1.8M total value (1,195,503 shares) as of 2026-Q1. Top holders: VANGUARD, VANGUARD, BlackRock,. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 726,290 | $1.1M | 60.8% | — |
| 2 | VANGUARD FIDUCIARY TRUST CO | 141,796 | $208.4K | 11.9% | — |
| 3 | BlackRock, Inc. | 122,254 | $179.7K | 10.2% | DOUBLED +167.0% |
| 4 | Rathbones Group PLC | 87,045 | $128.0K | 7.3% | NEAR_EXIT -79.4% |
| 5 | STATE STREET CORP | 75,600 | $111.1K | 6.3% | ADD +90.9% |
| 6 | CITIGROUP INC | 14,835 | $21.8K | 1.2% | — |
| 7 | RAYMOND JAMES FINANCIAL INC | 12,800 | $18.8K | 1.1% | — |
| 8 | MORGAN STANLEY | 8,394 | $12.3K | 0.7% | NEAR_EXIT -85.6% |
| 9 | WOLVERINE ASSET MANAGEMENT LLC | 6,489 | $9.5K | 0.5% | DOUBLED +292.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 1,655 | 6,489 | +292.1% | $9.5K | 2026-Q1 |
| VANGUARD GROUP INC | ADD | 613,272 | 842,049 | +37.3% | $1.2M | 2025-Q4 |
| DnB Asset Management AS | ADD | 73,705 | 136,473 | +85.2% | $193.8K | 2025-Q4 |
| STATE STREET CORP | ADD | 39,600 | 75,600 | +90.9% | $107.4K | 2025-Q4 |
| MARSHALL WACE, LLP | DOUBLED | 42,041 | 145,482 | +246.0% | $331.7K | 2025-Q3 |
| BlackRock, Inc. | DOUBLED | 40,405 | 107,871 | +167.0% | $245.9K | 2025-Q3 |
| Rathbones Group PLC | NEAR_EXIT | 433,182 | 89,178 | -79.4% | $203.3K | 2025-Q3 |
| DnB Asset Management AS | ADD | 43,024 | 73,705 | +71.3% | $168.0K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 258 | 118 | -54.3% | $269.00 | 2025-Q3 |
| VANGUARD GROUP INC | ADD | 416,866 | 623,054 | +49.5% | $1.5M | 2025-Q2 |
| UBS Group AG | DOUBLED | 73,607 | 173,187 | +135.3% | $429.5K | 2025-Q2 |
| UBS Group AG | TRIM | 126,516 | 73,607 | -41.8% | $84.6K | 2025-Q1 |
| MORGAN STANLEY | NEAR_EXIT | 66,295 | 9,564 | -85.6% | $11.0K | 2025-Q1 |
| VANGUARD GROUP INC | ADD | 105,403 | 184,741 | +75.3% | $522.8K | 2024-Q4 |
| UBS Group AG | DOUBLED | 39,106 | 126,516 | +223.5% | $358.0K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 114,122 | 66,295 | -41.9% | $187.6K | 2024-Q4 |
| STATE STREET CORP | DOUBLED | 14,600 | 39,600 | +171.2% | $112.1K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 3,395 | 114,122 | +3261.5% | $121.0K | 2024-Q3 |
| VANGUARD GROUP INC | ADD | 61,531 | 105,403 | +71.3% | $111.7K | 2024-Q3 |
5 unique insiders with 13 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | DiMaio John Michael | Director | AWARD | 15,000 | $2.12 | $31.8K |
| May 28, 2026 | DiMaio John Michael | Director | AWARD | 2,500 | $2.36 | $5.9K |
| May 26, 2026 | DiMaio John Michael | Director | AWARD | 32,233 | $2.61 | $84.1K |
| May 18, 2026 | Cotton Richard John | Director | AWARD | 8,818 | $2.40 | $21.2K |
| May 15, 2026 | DiMaio John Michael | Director | AWARD | 1,887 | $2.12 | $4.0K |
| May 15, 2026 | Cotton Richard John | Director | AWARD | 5,882 | $2.33 | $13.7K |
| Apr 24, 2026 | Sadagopan Deepak | Director | AWARD | 25,000 | — | — |
| Apr 24, 2026 | Cotton Richard John | Director | AWARD | 29,850 | — | — |
| Apr 24, 2026 | Capone Vincent S. | Chief Executive Officer | AWARD | 100,000 | — | — |
| Apr 24, 2026 | Snyder Marion Ann | Director | AWARD | 25,000 | — | — |
| Apr 24, 2026 | DiMaio John Michael | Director | AWARD | 100,000 | — | — |
| Mar 27, 2026 | Capone Vincent S. | Chief Executive Officer | AWARD | 16,750 | $1.52 | $25.5K |
| Mar 27, 2026 | DiMaio John Michael | Director | AWARD | 7,619 | $1.58 | $12.0K |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
MIXED
6/10
Spectral AI reported FY 2025 revenue of $19.7 million, down 33.5% YoY, with Q4 revenue halving to $3
Mar 24, 2026
BULLISH
8/10
Spectral AI (MDAI) announced $31.7 million in additional non-dilutive funding from BARDA to advance
Mar 18, 2026
NEUTRAL
3/10
Spectral AI announced it will release Q4 and full-year 2025 financial results on March 24, 2026, fol
Mar 10, 2026
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 3 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$5.42 mean target
+197.6% upside
Strong Buy (1.00)
$4.00 Low
$6.25 High
| Metric | Value |
|---|---|
| Current Price | $1.82 |
| Target Low | $4.00 |
| Target Mean | $5.42 |
| Target Median | $6.00 |
| Target High | $6.25 |
| # Analysts | 3 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.14 | $-0.14 | $-0.14 | 54.8% | — | 1↑ 0↓ | $0.0B | -10.2% | 1 |
| Next Q 2026-09-30 |
$-0.14 | $-0.14 | $-0.14 | -7.7% | — | 1↑ 0↓ | $0.0B | 27.3% | 1 |
| Current FY 2026-12-31 |
$-0.53 | $-0.53 | $-0.53 | -82.8% | — | 0↑ 1↓ | $0.0B | -4.8% | 1 |
| Next FY 2027-12-31 |
$-0.94 | $-0.94 | $-0.94 | -77.4% | — | — | $0.0B | 24.5% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.140 | |
| 7d ago | $-0.140 | |
| 30d ago | $0.000 | -0.140 |
| 60d ago | $0.000 | -0.140 |
| 90d ago | $-0.260 | +0.120 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 27, 2026 | BTIG | MAINTAIN | Buy | Buy |
| May 26, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Mar 25, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 10, 2026 | BTIG | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
85°
Bullish
Bearish
Neutral
Bullish
22 mentions
18 bullish
0 bearish
19 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 3, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 2, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 2, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 2, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 27, 2026 | 2 | 67° Warm | 2 | 0 | 2 |
| May 27, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 24, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 24, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 14, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 14, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 19, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Mar 19, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Mar 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
MDAI - FDA APPROVED
▲ 1
💬 0
⚡ 0.5
$MDAI JUST GOT A LIFT IN VALUE. $MDAI
▲ 1
💬 0
⚡ 0.5
MDAI - FDA APPROVED NOW IS THE TIME - TAKE A LOOK!
▲ 1
💬 0
⚡ 0.5
MDAI Officially Announces FDA Approval!
▲ 1
💬 1
⚡ 0.5
$MDAI Just Received FDA Approval
▲ 1
💬 1
⚡ 0.5
MDAI $31.7M government grant, $36,83M market cap, FDA decision most likely coming soon
▲ 1
💬 0
⚡ 0.5
**MDAI $31.7M government grant, $36,83M market cap, FDA decision most likely coming soon**
▲ 1
💬 1
⚡ 0.5
MDAI up 30% aftermarket,
▲ 2
💬 1
⚡ 0.5
Jun 12, 2026
other
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
<p align="justify">DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)</strong>, an
Jun 11, 2026
other
Spectral AI to Participate in 2026 British Burn Association Annual Conference
Company Will Showcase FDA-Cleared DeepView® System for Burn Indication <pre>Company Will Showcase FDA-Cleared DeepView® System for Burn Indication</pr
May 21, 2026
short_volume
Short Volume: MDAI — 55.7% short (0.3M / 0.6M)
Short: 314,914 | Exempt: 0 | TRF Vol: 565,298 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: MDAI — 61.4% short (0.3M / 0.5M)
Short: 320,189 | Exempt: 3,575 | TRF Vol: 521,152 | Short Ratio: 61.4% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: MDAI — 58.3% short (0.4M / 0.7M)
Short: 384,942 | Exempt: 54,575 | TRF Vol: 660,154 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
May 12, 2026
earnings
Spectral AI Announces 2026 First Quarter Financial Results
<p align="center"><strong><em>Development Work for DeepView</em></strong><em><sup>®</sup> </em><strong><em>Systems Continues with Support of Recently
May 12, 2026
earnings_calendar
MDAI Q1 2026 Earnings Scheduled — 2026-05-12
Apr 28, 2026
earnings
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
<p align="justify">DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)</strong>, an
Apr 22, 2026
routine
Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting
<p align="justify">DALLAS, April 22, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)</strong>, an
Apr 20, 2026
routine
Spectral AI Announces Annual Meeting of Stockholders
<p align="justify">DALLAS, April 20, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)</strong>, an
Apr 9, 2026
routine
Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting
DeepView System will be on Display at Booth #601 <pre>DeepView System will be on Display at Booth #601</pre>
Apr 8, 2026
other
Spectral AI Names David McGuire, CPA, as Chief Financial Officer
<p align="justify">DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- <strong>Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”)</strong>, an
Mar 24, 2026
earnings
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
<p align="left"><strong><u>Overview</u></strong></p>
Mar 24, 2026
earnings_calendar
MDAI Q4 2025 Earnings After Market Close — 2026-03-24
Mar 24, 2026
short_volume
Short Volume: MDAI — 59.3% short (0.4M / 0.7M)
Short: 400,257 | Exempt: 463 | TRF Vol: 674,901 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)